Swiss National Bank’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.6M | Hold |
145,600
| – | – | ﹤0.01% | 2044 |
|
|
2026
Q1 | $1.18M | Hold |
145,600
| – | – | ﹤0.01% | 2090 |
|
|
2025
Q4 | $1.51M | Buy |
145,600
+11,300
| +8% | +$119K | ﹤0.01% | 1992 |
|
|
2025
Q3 | $1.19M | Buy |
134,300
+18,600
| +16% | +$133K | ﹤0.01% | 2095 |
|
|
2025
Q2 | $668K | Buy |
115,700
+26,400
| +30% | +$162K | ﹤0.01% | 2267 |
|
|
2025
Q1 | $589K | Hold |
89,300
| – | – | ﹤0.01% | 2314 |
|
|
2024
Q4 | $778K | Hold |
89,300
| – | – | ﹤0.01% | 2305 |
|
|
2024
Q3 | $1.74M | Sell |
89,300
-8,000
| -8% | -$162K | ﹤0.01% | 1945 |
|
|
2024
Q2 | $2M | Sell |
97,300
-5,100
| -5% | -$105K | ﹤0.01% | 1815 |
|
|
2024
Q1 | $2.18M | Hold |
102,400
| – | – | ﹤0.01% | 1789 |
|
|
2023
Q4 | $1.47M | Sell |
102,400
-19,700
| -16% | -$194K | ﹤0.01% | 2015 |
|
|
2023
Q3 | $1.11M | Buy |
122,100
+7,900
| +7% | +$80.2K | ﹤0.01% | 2185 |
|
|
2023
Q2 | $1.21M | Sell |
114,200
-11,100
| -9% | -$131K | ﹤0.01% | 2193 |
|
|
2023
Q1 | $1.53M | Sell |
125,300
-12,000
| -9% | -$150K | ﹤0.01% | 2005 |
|
|
2022
Q4 | $1.7M | Buy |
137,300
+3,600
| +3% | +$52.3K | ﹤0.01% | 1995 |
|
|
2022
Q3 | $1.83M | Hold |
133,700
| – | – | ﹤0.01% | 1937 |
|
|
2022
Q2 | $2.45M | Hold |
133,700
| – | – | ﹤0.01% | 1779 |
|
|
2022
Q1 | $2.15M | Buy |
133,700
+9,600
| +8% | +$139K | ﹤0.01% | 1998 |
|
|
2021
Q4 | $1.74M | Hold |
124,100
| – | – | ﹤0.01% | 2158 |
|
|
2021
Q3 | $2.32M | Hold |
124,100
| – | – | ﹤0.01% | 1957 |
|
|
2021
Q2 | $2.59M | Sell |
124,100
-1,800
| -1% | -$44.7K | ﹤0.01% | 1931 |
|
|
2021
Q1 | $3.56M | Buy |
125,900
+2,200
| +2% | +$69.6K | ﹤0.01% | 1669 |
|
|
2020
Q4 | $4.04M | Buy |
123,700
+12,700
| +11% | +$446K | ﹤0.01% | 1485 |
|
|
2020
Q3 | $3.4M | Buy |
111,000
+1,500
| +1% | +$33.1K | ﹤0.01% | 1425 |
|
|
2020
Q2 | $1.78M | Buy |
109,500
+43,600
| +66% | +$629K | ﹤0.01% | 1776 |
|
|
2020
Q1 | $656K | Buy |
65,900
+1,000
| +2% | +$11.4K | ﹤0.01% | 2050 |
|
|
2019
Q4 | $892K | Buy |
64,900
+3,500
| +6% | +$51.9K | ﹤0.01% | 2201 |
|
|
2019
Q3 | $931K | Hold |
61,400
| – | – | ﹤0.01% | 2095 |
|
|
2019
Q2 | $1.21M | Buy |
61,400
+16,300
| +36% | +$271K | ﹤0.01% | 2010 |
|
|
2019
Q1 | $748K | Buy |
45,100
+2,900
| +7% | +$44.7K | ﹤0.01% | 2222 |
|
|
2018
Q4 | $592K | Hold |
42,200
| – | – | ﹤0.01% | 2285 |
|
|
2018
Q3 | $739K | Hold |
42,200
| – | – | ﹤0.01% | 2290 |
|
|
2018
Q2 | $768K | Buy |
+42,200
| New | +$715K | ﹤0.01% | 2308 |
|
Other funds holding KURA
SCM
BI
AC
ACM
Swiss National Bank's KURA Position: Q2 2026 in Review
Swiss National Bank held its Kura Oncology (KURA) position steady in Q2 2026 at 145,600 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2044.
Swiss National Bank first reported a position in KURA in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.04M in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- Swiss National Bank held 145,600 shares of Kura Oncology worth $1.6M as of Q2 2026.
- Swiss National Bank left its Kura Oncology share count unchanged in Q2 2026.
- Kura Oncology made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2044 holding.
- Swiss National Bank first reported a position in Kura Oncology in Q2 2018 and has held it in 33 quarters since.
- Swiss National Bank's Kura Oncology position peaked at $4.04M in Q4 2020.
- 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.